Interpace Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $29.8M | $51.5M | $2.3M |
| FY2020 | $28.2M | $45.7M | $2.8M |
| FY2021 | $34.3M | $38.4M | $2.7M |
| FY2022 | $32.5M | $16.0M | $4.8M |
| FY2023 | $26.8M | $16.0M | $5.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $29.8M | $51.5M | $2.3M |
| FY2020 | $28.2M | $45.7M | $2.8M |
| FY2021 | $34.3M | $38.4M | $2.7M |
| FY2022 | $32.5M | $16.0M | $4.8M |
| FY2023 | $26.8M | $16.0M | $5.6M |